Search

Pages

1. • Journal article

   • 

   Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

   Zhu, Jingjing[UCL] Petit, Pierre-Florent[UCL] Van den Eynde, Benoît[UCL] (2018) Cancer Immunology, Immunotherapy — (2018)
2. • Journal article

   • 

   Letter: does Helicobacter pylori infection limit the health effects of the Mediterranean diet?

   Vermorken, Alphons J M Zhu, Jingjing[UCL] Cui, Yali (2020) Alimentary pharmacology & therapeutics — Vol. 52, no.5, p. 935-936 (2020)
3. • Speech

   • 

   Understanding the tumor immune escape and the immune modulatory function of cancer stem cells

   Zhu, Jingjing[UCL] Colau, Didier[UCL] Boudhan, Loubna[UCL] Van den Eynde, Benoit[UCL] (2019) 17th International Congress of Immunology — Beijing, China
4. • Journal article

   • 

   The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure

   Vermorken, Alphons J.M. Zhu, Jingjing[UCL] Holvoet, Paul Cui, Yali (2021) Redox Biology — Vol. 44, p. 102011 (2021)
5. • Speech

   • 

   Invited Lecture: Understanding the tumor immune escape and the immune modulatory function of cancer stem cells

   Zhu, Jingjing[UCL] (2019) 17th International Congress of Immunology — Beijing, China
6. • Speech

   • 

   Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes

   Zhu, Jingjing[UCL] Céline G. Powis de Tenbossche Stefania Cané Didier Colau Van den Eynde, Benoit[UCL] (2017) Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference — Mainz/Frankfurt, Germany
7. • Speech

   • 

   Invited Lecture: Discovery of novel immuno-oncology targets

   Zhu, Jingjing[UCL] (2017) Departmental Research Seminar — National Engineering Center for Miniaturized Detection System, Northwest University
8. • Speech

   • 

   Generation and characterization of non-competitive furin-inhibiting nanobodies

   Declercq, Jeroen Zhu, Jingjing[UCL] Lindberg, Iris Ghassabeh, Gholamreza H. Meulemans, Sandra Vermorken, Alphons J.M. Van de Ven, Wim J.M. Muyldermans, Serge Creemers, John W.M. (2014) Proceedings: AACR 103rd Annual Meeting 2012 — Chicago, United States
9. • Speech

   • 

   Invited Lecture: Tumoral immune resistance based on apoptosis of tumor-infiltrating T cells in an inducible mouse melanoma model

   Zhu, Jingjing[UCL] (2019) Departmental Research Seminar — Dept. Pharmaceutical Chemistry, Peking Union Medical College
10. • Speech

    • 

    Invited Lecture: Deciphering the role of cancer stem cells in tumoral immune resistance in an autochthonous melanoma model

    Zhu, Jingjing[UCL] (2019) XI Melanoma Workshop 2019 — Otranto, Italy
11. • Speech

    • 

    Invited Lecture: T-cell mediated targeted delivery of anti-PD-L1 nanobodies overcomes poor antibody penetration and improves PD-L1 blocking at the tumor site

    Zhu, Jingjing[UCL] (2021) 6th Annual MarketandMarkets Biomarker and Companion Diagnostics Virtual Conference —
12. • Speech

    • 

    Inhibition of Proprotein convertase Furin as a target for cancer therapy

    Zhu, Jingjing[UCL] (2010) Invited Lecture — National Engineering Center for Miniaturized Detection System, Northwest University
13. • Speech

    • 

    Invited Lecture: Inhibition of Proprotein convertase Furin as a target for cancer therapy

    Zhu, Jingjing[UCL] (2010) Departmental Research Seminar — National Engineering Center for Miniaturized Detection System, Northwest University
14. • Speech

    • 

    Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes

    Zhu, Jingjing[UCL] Céline G. Powis de Tenbossche Stefania Cané Didier Colau Van den Eynde, Benoit[UCL] (2017) Ludwig Oxford 10th Anniversary Symposium — Oxford, United Kingdom
15. • Speech

    • 

    Invited Lecture: Local delivery of anti-PD-L1 nanobodies overcomes poor antibody penetration and allows improved blocking of PD-L1 at the tumor site

    Zhu, Jingjing[UCL] (2021) 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress —
16. • Speech

    • 

    Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies

    Petit, P-F.[UCL] Zhu, Jingjing[UCL] van den Eynde, B.J.[UCL] (2020) ESMO Immuno-Oncology Vitual Congress 2020 —
17. • Speech

    • 

    Uncovering molecular actors of IDO-mediated T cell dysfunction with genome-wide CRISPR/Cas9 knockout screens

    Bombart, Raphaële[UCL] Zhu, Jingjing[UCL] Van den Eynde, Benoit J. (2022) Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy —
18. • Speech

    • 

    T cells secreting nanobody-based immune checkpoint inhibitors

    Petit, Pierre-Florent[UCL] Zhu, Jingjing[UCL] Van den Eynde, Benoit[UCL] (2019) CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference — Paris, France
19. • Speech

    • 

    The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model

    Krendyukov, A. Kneisel, N. Zhu, Jingjing[UCL] Merz, C. Richards, D. Gieffers, C. van den Eynde, B. (2019) ESMO Immuno-Oncology Congress 2019 — Geneva, Switzerland
20. • Patent

    • 

    ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS

    Zhu, Jingjing[UCL] Van den Eynde, Benoit[UCL] (2021)
21. • Patent

    • 

    GUANABENZ AS AN ADJUVANT FOR IMMUNOTHERAPY

    Zhu, Jingjing[UCL] Van den Eynde, Benoit[UCL] (2020)
22. • Journal article

    • 

    Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes

    Zhu, Jingjing[UCL] (2023) bioRxiv — (2023)
23. • Patent

    • 

    ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER

    Zhu, Jingjing[UCL] Van den Eynde, Benoit[UCL] (2021)
24. • Journal article

    • 

    AHR and tryptophan metabolism: a collaborative dynamics of immune regulation

    Zhu, Jingjing Van den Eynde, Benoit[UCL] (2023) Genes and Immunity — (2023)
25. • Journal article

    • 

    Can niacin supplementation prevent congenital malformations associated with maternal use of proton pump inhibitors?

    Vermorken, Alphons J M Zhu, Jingjing[UCL] Ma, Le Cui, Yali (2023) European journal of nutrition — Vol. 62, no.2, p. 1051-1053 (2023)

Pages